Market Overview:
The global nebuliser devices market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in nebuliser devices. Based on type, the global nebuliser devices market is segmented into pneumatic nebulisers, ultrasonic nebulisers, and mesh nebulisers. Pneumatic Nebulisers are currently dominating the global market with a share of more than 50%. However, Ultrasonic Nebulizers are expected to grow at a higher CAGR during the forecast period as they are more efficient and cause less irritation as compared to pneumatic Nebulizers. Mesh Nebulizers are also gaining popularity due to their low cost and easy operability. Based on application, COPD is currently leading the global market for nebula device usage followed by cystic fibrosis and asthma applications respectively.
Product Definition:
Nebulisers are medical devices used to deliver medication in the form of a mist inhaled through the mouth and nose. Nebulisers are often used to treat breathing problems, such as asthma and chronic obstructive pulmonary disease (COPD). Nebuliser therapy is also used to deliver other medications, including antibiotics and cancer drugs.
Pneumatic Nebuliser:
Pneumatic nebuliser is a device used to dispense medication in the form of a mist. It is mainly used for the treatment of respiratory disorders such as asthma, COPD and pulmonary fibrosis among others. The pneumatic nebuliser works by compressed air which is forced into an enclosed chamber where the drugs are mixed with water or another liquid solution to form a mist which then goes towards delivering drug therapy.
Ultrasonic Nebuliser:
Ultrasonic Nebuliser is a device used to dispense liquid from nebulizer devices. It works on the principle of ultrasonic vibrations which break the liquid into small particles, thus making it easier for patients to breathe.
Application Insights:
The others segment includes conditions other than asthma, COPD, cystic fibrosis, and pneumonia. The application segment is sub-divided into diabetes mellitus, cardiovascular diseases (CVDs), nephrological disorders and others. Among these applications, the COPD segment held the largest market share in 2017 owing to a large patient base suffering from chronic bronchitis across the globe. According to estimates reported by WHO in 2018, over 1 billion people are living with COPD worldwide which is expected to increase to around 2 billion by 2050 globally resulting in huge potential demand for inhalation therapy devices such as nebulizers over the forecast period.
In addition, an increasing number of patients suffering from diabetes mellitus across various regions including North America and Europe is expected to boost industry growth during the study period due to rising awareness about available treatment options along with improved lifestyle habits among consumers regarding proper food intake.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare facilities, favorable reimbursement policies, and increasing awareness levels regarding new technologies are some of the major factors responsible for this dominance. Moreover, a high prevalence of chronic respiratory diseases such as asthma and COPD is also expected to drive the regional market during the forecast period. In addition, an increase in government initiatives pertaining to innovation in nebulizers is also anticipated to fuel growth over the next eight years.
Asia Pacific region is expected to witness lucrative growth during the forecast period owing to rising disposable income coupled with improving healthcare infrastructure and growing patient awareness about available treatment options in emerging countries such as China & India are some of them).
Growth Factors:
- Increasing prevalence of respiratory diseases: The global Nebuliser Devices market is expected to grow at a CAGR of 5.5% during the forecast period, owing to the increasing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis.
- Technological advancements: The development of novel technologies in Nebuliser Devices is anticipated to fuel the growth of this market during the forecast period. For instance, in January 2017, Omron Healthcare Inc., launched its new product “NE-U22” which is a portable ultrasonic nebulizer that does not require any power supply or batteries and can be operated with just one hand. This product has been designed for use by patients who are on-the-go and helps reduce medication wastage.
- Rising geriatric population: The global geriatric population is increasing at a rapid pace due to factors such as improved healthcare facilities and rising life expectancy rates across the world. This is expected to drive demand for Nebuliser Devices in the coming years as these devices are commonly used for treating respiratory disorders among elderly patients..
Scope Of The Report
Report Attributes
Report Details
Report Title
Nebuliser Devices Market Research Report
By Type
Pneumatic Nebuliser, Ultrasonic Nebuliser, Mesh Nebuliser
By Application
COPD, Cystic Fibrosis, Asthma, Others
By Companies
PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips, Yuwell, Leyi, Folee, Medel S.p.A, Briggs Healthcare, 3A Health Care, Trudell Medical International, GF Health Products
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Nebuliser Devices Market Report Segments:
The global Nebuliser Devices market is segmented on the basis of:
Types
Pneumatic Nebuliser, Ultrasonic Nebuliser, Mesh Nebuliser
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
COPD, Cystic Fibrosis, Asthma, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- PARI GmbH
- Omron
- Drive DeVilbiss Healthcare
- Philips
- Yuwell
- Leyi
- Folee
- Medel S.p.A
- Briggs Healthcare
- 3A Health Care
- Trudell Medical International
- GF Health Products
Highlights of The Nebuliser Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pneumatic Nebuliser
- Ultrasonic Nebuliser
- Mesh Nebuliser
- By Application:
- COPD
- Cystic Fibrosis
- Asthma
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nebuliser Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A Nebuliser Devices is a medical device that helps to deliver medication directly to the lungs. It works by using a compressor and an inhaler to create a high-pressure stream of air, which helps the medicine travel deeper into the lungs.
Some of the key players operating in the nebuliser devices market are PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips, Yuwell, Leyi, Folee, Medel S.p.A, Briggs Healthcare, 3A Health Care, Trudell Medical International, GF Health Products.
The nebuliser devices market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nebuliser Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Nebuliser Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Nebuliser Devices Market - Supply Chain
4.5. Global Nebuliser Devices Market Forecast
4.5.1. Nebuliser Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Nebuliser Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Nebuliser Devices Market Absolute $ Opportunity
5. Global Nebuliser Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Nebuliser Devices Market Size and Volume Forecast by Type
5.3.1. Pneumatic Nebuliser
5.3.2. Ultrasonic Nebuliser
5.3.3. Mesh Nebuliser
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Nebuliser Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Nebuliser Devices Market Size and Volume Forecast by Application
6.3.1. COPD
6.3.2. Cystic Fibrosis
6.3.3. Asthma
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Nebuliser Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Nebuliser Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Nebuliser Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Nebuliser Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Nebuliser Devices Demand Share Forecast, 2019-2026
9. North America Nebuliser Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Nebuliser Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Nebuliser Devices Market Size and Volume Forecast by Application
9.4.1. COPD
9.4.2. Cystic Fibrosis
9.4.3. Asthma
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Nebuliser Devices Market Size and Volume Forecast by Type
9.7.1. Pneumatic Nebuliser
9.7.2. Ultrasonic Nebuliser
9.7.3. Mesh Nebuliser
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Nebuliser Devices Demand Share Forecast, 2019-2026
10. Latin America Nebuliser Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Nebuliser Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Nebuliser Devices Market Size and Volume Forecast by Application
10.4.1. COPD
10.4.2. Cystic Fibrosis
10.4.3. Asthma
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Nebuliser Devices Market Size and Volume Forecast by Type
10.7.1. Pneumatic Nebuliser
10.7.2. Ultrasonic Nebuliser
10.7.3. Mesh Nebuliser
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Nebuliser Devices Demand Share Forecast, 2019-2026
11. Europe Nebuliser Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Nebuliser Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Nebuliser Devices Market Size and Volume Forecast by Application
11.4.1. COPD
11.4.2. Cystic Fibrosis
11.4.3. Asthma
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Nebuliser Devices Market Size and Volume Forecast by Type
11.7.1. Pneumatic Nebuliser
11.7.2. Ultrasonic Nebuliser
11.7.3. Mesh Nebuliser
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projectionsby Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Nebuliser Devices Demand Share, 2019-2026
12. Asia Pacific Nebuliser Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Nebuliser Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Nebuliser Devices Market Size and Volume Forecast by Application
12.4.1. COPD
12.4.2. Cystic Fibrosis
12.4.3. Asthma
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Nebuliser Devices Market Size and Volume Forecast by Type
12.7.1. Pneumatic Nebuliser
12.7.2. Ultrasonic Nebuliser
12.7.3. Mesh Nebuliser
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Nebuliser Devices Demand Share, 2019-2026
13. Middle East & Africa Nebuliser Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Nebuliser Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Nebuliser Devices Market Size and Volume Forecast by Application
13.4.1. COPD
13.4.2. Cystic Fibrosis
13.4.3. Asthma
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Nebuliser Devices Market Size and Volume Forecast by Type
13.7.1. Pneumatic Nebuliser
13.7.2. Ultrasonic Nebuliser
13.7.3. Mesh Nebuliser
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Nebuliser Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Nebuliser Devices Market: Market Share Analysis
14.2. Nebuliser Devices Distributors and Customers
14.3. Nebuliser Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. PARI GmbH
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Omron
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Drive DeVilbiss Healthcare
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Philips
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Yuwell
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Leyi
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Folee
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Medel S.p.A
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Briggs Healthcare
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. 3A Health Care
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Trudell Medical International
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. GF Health Products
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook